USP 797 Sterile Compounding
ProSciento’s drug compounding procedures strictly adhere to USP 797 thus ensuring the safety of clinical study participants and supporting the successful execution of clinical trials. ProSciento’s Clinical Research Unit (CRU) […]
In-Patient Extended Stay Capabilities
ProSciento’s specialized early phase Clinical Research Unit (CRU) accommodates extended in-patient studies up to eight weeks, supported by a 24/7 medical team. This capacity supports protocols for complex early phase […]
Specialized Methodologies
At ProSciento, we are committed to contributing to scientific discoveries and advancing clinical methods that support new therapeutic development worldwide. The breadth of our team’s expertise makes ProSciento a unique […]
Medical Monitoring & Pharmacovigilance
ProSciento’s Medical Monitoring and Pharmacovigilance (PV) teams bring an unmatched level of scientific and therapeutic area expertise to ensure data integrity, safety, and mitigate risk 24/7 by working closely with […]
Data Management & Biostatistics
Good quality data are the backbone of a clinical trial as they determine if a study meets its primary and secondary endpoints. What further sets ProSciento apart is our team’s […]
Investigational Product Management
ProSciento has a dedicated Pharmaceutical Services (PS) group that takes a science-driven approach to IP Management. The group consists of pharmacists and researchers with longstanding expertise in early-stage metabolic trials—more […]
Clinical Monitoring
ProSciento’s Clinical Monitoring team consists of CRA professionals with focused expertise in metabolic clinical studies. This model is different in the industry, in that our CRAs are not working across […]
Site Selection & Vendor Management
Selecting suitable sites with access to patients meeting protocol eligibility requirements is paramount to study enrollment success in clinical research. To bolster site selection, ProSciento has a strong global network […]
Patient Enrollment & Engagement
ProSciento provides its clients a significant advantage in patient access and enrollment via its PRO PASS® diagnostic IRB-approved protocol deployed at sites across the nation and growing globally that provides […]
Regulatory Affairs
ProSciento’s therapeutic-specific scientific and regulatory expertise provides a distinct advantage in navigating the evolving global regulatory environment. Our Regulatory Affairs services typically begin with assessing IND readiness, analyzing regulatory options, […]